Protective effects of 2-mercaptoethane sulfonate (MESNA) on protamine sulfate induced bladder damage

Marmara Medical Journal

Volumn 18, Issue 1, 2005, Pages 6-12

  Saǧlam, Beyhan ^a   Cikler, Esra ^a   Zeybek, Ali ^b   Çetinel, Şule ^a,c   Ercan, Feriha ^a   Şener, Göksel ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

MESNA; Protamine sulfate; Urinary bladdder

Indexed keywords

GLUTATHIONE; GLYCOSAMINOGLYCAN; MALONALDEHYDE; MESNA; PROTAMINE SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER INJURY; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; INFLAMMATORY CELL; MAST CELL; MICROSCOPY; NONHUMAN; PROPHYLAXIS; RAT; SCANNING ELECTRON MICROSCOPY;

EID: 33846805732     PISSN: 10191941     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Horrow JC. Protamine a review of its toxicity. Anesth Analg 1985;64:348-361.
2. Peterson MW, Gruenhaupt D. Protamine interaction with the epithelial cell surface. J Appl Physiol 1992;72: 236-241.
3. Quinton PM, Philpott CW. A role for anionic sites in epithelial architecture. J Cell Biol 1973;56:787-796.
4. Tzan CJ, Berg J, Lewis SA. Effect of protamine sulfate on the permeability properties of the mammalian bladder. J Membrane Biol 1993;133:227-242.
5. Niku DS, Stein PC, Scherz HC, Parsons CL. A new method for cytodestruction of bladder epithelium using protamine sulfate and urea. J Urol 1994;152:1025-1028.
6. Johansson SL, Fall M. Pathology of interstitial cystitis. Urol Clin North Am 1994;21:55-62.
7. Fall M, Johansson SL, Vahlne A. A clinicopathological and virological study of interstitial cystitis. J Urol 1985;133:771-773.
8. Sant GR. Diagnosis of interstitial cystitis. A clinical, endoscopic and pathologic approach. In: Hanno PM, Staskan DR, Krane RJ, Wein AJ. Interstitial Cystitis. London.: Springer. 1990: 107.
9. Fowler JE, Jr Lynes WL, Lau JLT, Ghosh L, Mounzer A. Interstitial cystitis is associated with intraurethelial Tamm-Horsfall protein. J Urol 1988;140:1385-1389.
10. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988;140:203-206.
11. Gressier B, Lebegue S, Brunet C, et al: Pro-oxidant properties of methotrexate: evaluation and prevention by anti-oxidant drug. Pharmazie 1994;49:679-681.
12. Gressier B, Lebegue N, Brunet C, et al. Scavenging of reactive oxygen species by letosteine, a molecule with two blocked-SH groups, omparison with free -SH drugs. Pharm World Sci 1995;17:76-80.
13. Goren MP, McKenna LM, Goodman TL. Combined intravenous and oral mesna in outpatients treated with ifosfamide. Cancer Chemother Pharmacol 2003; 40:371-375.
14. Kurovski V, Wagner T. Urinary excretion of ifosfamide, 4-hydroxyfosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy. Cancer Chemother Pharmacol 1997;39:431-439.
15. Berrigan MJ, Marinello AJ, Pavelic Z, Williams CJ, Struck RF, Gurtoo HL. Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism. Cancer Res 1982;42:3688-3695.
16. West NJ. Prevention and treatment of hemorrhagic cystitis. Pharmacother 1997;17:696-706.
17. Nishikawa A, Morse MA, Chung FL. Inhibitory effects of 2-mercaptoethane sulfonate and 6-phenylhexyl isothiocyanate on urinary bladder tumorigenesis in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Cancer Lett 2003;193:11-16.
18. Umemura T, Hasegawa R, Sai-Kato K, et al. Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate. Jpn J Cancer Res 1996;87:882-886.
19. Beuge JA, Aust SD. Microsomal lipid peroxidation. Method Enzymol 1978;52:302-311.
20. Beutler E. Glutathione in red blood cell metabolism. A manual of Biochemical Methods. Published by Grune and Stratton. New York, 1975: 112-114.
21. Lilly JD, Parsons L. Bladder surface glycosaminoglycans. Is a human epithelial permeability barrier?. Surg. Gynecol Obstet 1990;171:493-496.
22. Parsons CL, Lilly JD, Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 1991;145:732-735.
23. Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol 1994;73:504-507.
24. Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H. Bladder surface glycosaminoglycans: An epithelial permeability barrier. J Urol 1990;143:139-142.
25. Anderström CRK, Fall M, Johansson SL. Scanning electron microscopic findings in interstitial cystitis. Br J Urol 1989;63:270-275.
26. Skinner R, Sharkey IM., Pearson ADJ, Craft AW. Ifosfamide, mesna, and nephrotoxicity in children. J Clin Oncol 1993;11:173-190.
27. Lord-Fontaine S, Averill DA. Enhancement of cytotoxicity of hydrogen peroxide by hyperthermia in Chinese hamster ovary cells: role of antioxidant defenses. Arch Biochem Biophys 1999;363:283-295.
28. Souid AK, Fahey RC, Aktas MK, et al. Blood thiols following amifostine and mesna infusions, a pediatric oncology group study. Drug Metab Dispos 2001;29:1460-1466.
29. Garcia JJ, Reiter RJ, Guerrero JM, Escames G, Yu BP, Oh CS, Munoz-Hoyos A. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997:408:297-300.
30. Ross D. Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. Pharmacol Ther 1988;37:231-249.
31. Kabasakal L, Sehirli AO, Cetinel S, Cikler E, Gedik N, Sener G. Mesna (2-mercaptoethane sulfonate) prevents ischemia/reperfusion induced renal oxidative damage in rats. Life Sci 2004, Sep 24;75:2329-2340.
32. Vieira MM, Macedo FY, Filho JN, et al., Ternatin, a flavonoid, prevents cyclophosphamide and ifosfamide-induced hemorrhagic cystitis in rats. Phytother Res 2004 Feb;18:135-141.
33. Granger DN, Korthuis RJ. Physiological mechanisms of postischemic tissue injury. Annu Rev Physiol. 1995;57:311-332.
34. Zimmerman BJ, Grisham MB, Granger DN: Role of oxidants in ischemia-reperfusion induced granulocyte infiltration. Am J Physiol 1990;258:G185-G190.
35. Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology 2001;57 (suppl.6A):47-55.